The effect of growth hormone on biogenic amines in the hepatic portal circulation of the dog.
The effects of a spike concentration of growth hormone (GH) on hepatic portal and peripheral levels of free serotonin and catecholamines were studied by improved radioenzymatic methods in trained, conscious, normal, adult dogs fitted with an indwelling portal catheter. An injection of ovine GH (6 or 100 micrograms/kg) into a cephalic vein produced in the hepatic portal circulation a transient, statistically significant rise of serotonin and a concomitant significant reduction in the concentration of dopamine, norepinephrine, and epinephrine. No change was found in the peripheral circulation, partly because the amines were conjugated to sulfates and glucuronides and these derivatives are not detectable by our assays. Thus, a pulse of GH not only stimulates the release of pancreatic hormones and glucose turnover, but also affects the portal profile of glucoregulatory bioamines. The present investigation lends further support to our view that the splanchnic area represents an endocrine system whose preferential target is the liver.
D000818:Animals; D001679:Biogenic Amines / Q000097:blood*; D004285:Dogs; D004298:Dopamine / Q000097:blood; D004837:Epinephrine / Q000097:blood; D005260:Female; D005966:Glucuronidase / Q000494:pharmacology; D013006:Growth Hormone / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D009638:Norepinephrine / Q000097:blood; D011168:Portal System / Q000378:metabolism*; D012701:Serotonin / Q000097:blood; D012756:Sheep; D013429:Sulfatases / Q000494:pharmacology
D001679:Biogenic Amines; D012701:Serotonin; D013006:Growth Hormone; D013429:Sulfatases; D005966:Glucuronidase; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine